Blueprint Medicines Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -0.11%63.131.0%$460.49m
AMGNAmgen, Inc. 0.18%240.941.3%$449.35m
BIIBBiogen, Inc. 0.01%286.161.4%$389.08m
ILMNIllumina, Inc. -0.38%324.713.5%$319.29m
VRTXVertex Pharmaceuticals, Inc. -1.03%233.081.9%$297.00m
REGNRegeneron Pharmaceuticals, Inc. -0.56%383.422.6%$228.58m
EXASEXACT Sciences Corp. -0.47%89.3624.0%$203.43m
ALXNAlexion Pharmaceuticals, Inc. 1.28%113.952.0%$196.36m
ITCIIntra-Cellular Therapies, Inc. 1.20%26.959.0%$177.91m
INCYIncyte Corp. -0.19%80.472.5%$149.09m
SRPTSarepta Therapeutics, Inc. -1.34%128.5514.6%$143.19m
ARWRArrowhead Pharmaceuticals, Inc. -0.49%56.8311.4%$132.82m
SGENSeattle Genetics, Inc. 1.12%108.866.1%$126.83m
BMRNBioMarin Pharmaceutical, Inc. -0.64%88.564.3%$108.58m
AAgilent Technologies, Inc. 0.68%90.071.6%$106.43m

Company Profile

Blueprint Medicines Corp. is a precision therapy company, which focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.